US researchers have unveiled a new genomic scoring system designed to predict the risk of progression to multiple myeloma from pre-cursor conditions.
The 鈥淢M-like score鈥� can assess the risk of progression to active cancer and indicate the severity...
9 months ago
A new study has identified key factors that indicate when patients with acute myeloid leukaemia (AML) are unlikely to respond to venetoclax.
Researchers in Colorado, USA, found that monocytic disease was linked to poor outcomes, especially if they...
9 months ago
